Skip to content

Calcitonin-salmon studies: 133 papers with results

Page 3 of 3

Calcitonin-salmon has 1,643 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.

  1. Absorption of inorganic phosphate in the human jejunum and its inhibition by salmon calcitonin.

    Juan D · The Journal of clinical endocrinology and metabolism · 1976

    Non-randomized trial · 8 results

  2. Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin.

    Aloia JF · Calcified tissue international · 1987

    Non-randomized trial · 1 result

  3. Calcitonin in the treatment of intractable pain from advanced malignancy.

    Allan E · Pharmatherapeutica · 1983

    Non-randomized trial · 2 results

  4. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

    Mazzuoli GF · Calcified tissue international · 1986

    Non-randomized trial · 3 results

  5. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.

    Adami S · Bone · 1995

    Non-randomized trial · 2 results

  6. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study.

    Gonnelli S · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1996

    Non-randomized trial · 4 results

  7. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.

    Holloway L · The Journal of clinical endocrinology and metabolism · 1997

    Non-randomized trial · 4 results

  8. Effects of salmon calcitonin on the bone loss induced by ovariectomy.

    Mazzuoli GF · Calcified tissue international · 1990

    Non-randomized trial · 1 result

  9. Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.

    Sileghem A · Annals of the rheumatic diseases · 1992

    Non-randomized trial · 6 results

  10. Calcium and salmon calcitonin in treatment of osteoporosis.

    Jowsey J · The Journal of clinical endocrinology and metabolism · 1978

    Non-randomized trial · 3 results

  11. Intrapulmonary drug delivery of salmon calcitonin.

    Deftos LJ · Calcified tissue international · 1997

    Non-randomized trial · 5 results

  12. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.

    Montemurro L · Calcified tissue international · 1991

    Observational study · 4 results

  13. Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis.

    Rizzato G · Sarcoidosis · 1988

    Observational study · 2 results

  14. Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy.

    Karsdal MA · European journal of clinical pharmacology · 2010

    Observational study · 10 results

  15. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.

    Karsdal MA · BMC musculoskeletal disorders · 2010

    Observational study · 1 result

  16. Transmucosal macromolecular drug delivery.

    Prego C · Journal of controlled release : official journal of the Controlled Release Society · 2005

    Animal study (in vivo) · rat · 3 results

  17. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats.

    Lutz TA · International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · 2001

    Animal study (in vivo) · rat · 1 result

  18. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.

    Mollet A · Physiology & behavior · 2004

    Animal study (in vivo) · rat · 4 results

  19. The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.

    Mosekilde L · Endocrinology · 1994

    Animal study (in vivo) · rat · 3 results

  20. High affinity amylin binding sites in rat brain.

    Beaumont K · Molecular pharmacology · 1993

    Ex vivo tissue · rat · 2 results

  21. Osteoblastic cells are involved in osteoclast formation.

    Takahashi N · Endocrinology · 1988

    In vitro (cells) · mouse · 1 result

  22. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

    Takahashi N · Endocrinology · 1988

    In vitro (cells) · mouse · 2 results

  23. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.

    Udagawa N · Endocrinology · 1989

    In vitro (cells) · mouse · 1 result

  24. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.

    Chambers TJ · Endocrinology · 1985

    In vitro (cells) · rabbit · 1 result

  25. Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase.

    Schwartzman M · Nature · 1985

    In vitro (cells) · rabbit · 1 result

  26. Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures.

    Akatsu T · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1989

    In vitro (cells) · mouse · 3 results

  27. A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins.

    Arnett TR · Endocrinology · 1987

    In vitro (cells) · chick and rat · 4 results

  28. Preparation and characterization of a mouse osteoclast-like multinucleated cell population.

    Akatsu T · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1992

    In vitro (cells) · mouse and rat · 4 results

  29. Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin.

    Forrest SM · Calcified tissue international · 1985

    In vitro (cells) · rat · 6 results

  30. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.

    Britto JM · Endocrinology · 1994

    In vitro (cells) · rat · 1 result

  31. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells.

    Takahashi N · Endocrinology · 1988

    In vitro (cells) · mouse · 7 results

  32. Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat.

    Warshawsky H · The Journal of cell biology · 1980

    Not a test of Calcitonin-salmon alone · 4 results

  33. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.

    Prego C · Journal of controlled release : official journal of the Controlled Release Society · 2006

    Not a test of Calcitonin-salmon alone · 2 results

How PepBank reports evidence